BKL +22.75%: The vitamins company rallied today after Kirin struck a deal worth $95 per share ($1.88bn) to acquire them as the Japanese brewer pushes into health products. The bid is 23.7% premium to Wednesday’s close, is all cash, and the board unanimously recommends it. The deal is expected to close in the third quarter and, unlike many recent bids, has a very high chance of completing.
MM is neutral BKL believing the deal will be successful
Add To Hit List
